Showing results (1551-1560 of 1,585) with videos related to

Sort By:
Pageof 159
Modern Rheumatology|June 24, 2026
Nervous system involvement in primary Sjögren's syndrome: analysis from the Sjögrenser registryXimena Larco-Rojas, Mónica Fernández Castro, Carlos Sánchez-Piedra, et al.
Pediatric Nephrology (Berlin, Germany)|January 4, 2021
Acute peritoneal dialysis, complications and outcomes in 389 children with STEC-HUS: a multicenter experiencePaula A Coccia, Flavia B Ramírez, Angela D C Suárez, et al.
Trials|July 24, 2023
The statistical analysis plan for the unification of treatments and interventions for tinnitus patients randomized clinical trial (UNITI-RCT)Jorge Piano Simoes, Stefan Schoisswohl, Winfried Schlee, et al.
Lancet Regional Health. Americas|September 20, 2021
A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trialArturo Chang-Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruiz, et al.
Nature Communications|July 24, 2019
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon responseKrist Helen Antunes, José Luís Fachi, Rosemeire de Paula, et al.
Endoscopy|June 22, 2026
PolyDeep Advance 3: Randomized Clinical Trial comparing PolyDeep-assisted and conventional colonoscopy for adenoma detection rate in a colorectal cancer screening programPedro Davila-Piñón, Astrid Irene Díez-Martín, Alba Nogueira-Rodríguez, et al.
Clinical Endocrinology|August 12, 2025
Thyroid Hormone Treatment for Hypercholesterolemia in Euthyroid Patients: Results From a European Survey of Thyroid SpecialistsJuan C Galofré, Juan J Díez, Roberto Attanasio, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 20, 2022
Open-label phase I/II clinical trial of SARS-CoV-2 receptor binding domain-tetanus toxoid conjugate vaccine (FINLAY-FR-2) in combination with receptor binding domain-protein vaccine (FINLAY-FR-1A) in childrenRinaldo Puga-Gómez, Yariset Ricardo-Delgado, Chaumey Rojas-Iriarte, et al.
Therapeutic Advances in Neurological Disorders|December 30, 2025
Real-world effectiveness of horizontal switching between disease-modifying therapies in multiple sclerosis: a retrospective analysis of the MSBase RegistryEnrique Gomez-Figueroa, Patricia Orozco-Puga, Cynthia Patricia Corona-Vázquez, et al.
Scientific Reports|March 8, 2016
An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity DisorderLeandro de Araújo Lima, Ana Cecília Feio-dos-Santos, Sintia Iole Belangero, et al.
Pageof 159